Jump to content

Recommended Posts

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Similar Topics

    • By Space Force
      CMSSF Bentivegna visited Colorado and met with two groups of USSF senior noncomissioned officers to discuss their evolving roles in the USSF.

      View the full article
    • By NASA
      6 min read
      Preparations for Next Moonwalk Simulations Underway (and Underwater)
      In-person participants L-R standing: Dave Francisco, Joanne Kaouk, Dr. Richard Moon, Dr. Tony Alleman, Dr. Sean Hardy, Sarah Childress, Kristin Coffey, Dr. Ed Powers, Dr. Doug Ebersole, Dr. Steven Laurie, Dr. Doug Ebert; L-R seated: Dr. Alejandro Garbino, Dr. Robert Sanders, Dr. Kristi Ray, Dr. Mike Gernhardt, Dr. Joseph Dervay, Dr. Matt Makowski). Not pictured: Dr. Caroline Fife In June 2024, the NASA Office of the Chief Health and Medical Officer (OCHMO) Standards Team hosted an independent assessment working group to review the status and progress of research and clinical activities intended to mitigate the risk of decompression sickness (DCS) related to patent foramen ovale (PFO) during spaceflight and associated ground testing and human subject studies.
      Decompression sickness (DCS) is a condition which results from dissolved gases (primarily nitrogen) forming bubbles in the bloodstream and tissues. It is usually experienced in conditions where there are rapid decreases in ambient pressure, such as in scuba divers, high-altitude aviation, or other pressurized environments. The evolved gas bubbles have various physiological effects and can obstruct the blood vessels, trigger inflammation, and damage tissue, resulting in symptoms of DCS. NASA presently classifies DCS into two categories: Type I DCS, which is less severe, typically leads to musculoskeletal symptoms including pain in the joints or muscles, or skin rash. Type II DCS is more severe and commonly results in neurological, inner ear, and cardiopulmonary symptoms. The risk of DCS in spaceflight presents during extravehicular activities (EVAs) in which astronauts perform mission tasks outside the spaceflight vehicle while wearing a pressurized suit at a lower pressure than the cabin pressure. DCS mitigation protocols based on strategies to reduce systemic nitrogen load are implemented through the combination of habitat environmental parameters, EVA suit pressure, and breathing gas procedures (prebreathe protocols) to achieve safe and effective mission operations. The pathophysiology of DCS has still not been fully elucidated since cases occur despite the absence of detected gas bubbles but includes right to left shunting of venous gas emboli (VGE) via several potential mechanisms, one of which is a Patent Foramen Ovale (PFO).
      From: Dr. Schochet & Dr. Lie, Pediatric Pulmonologists
      Reference OCHMO-TB-037 Decompression Sickness (DCS) Risk Mitigation technical brief for additional information.
      A PFO is a shunt between the right atrium and the left atrium of the heart, which is a persisting remnant of a physiological communication present in the fetal heart. Post-natal increases in left atrial pressure usually force the inter-septal valve against the septum secundum and within the first 2 years of life, the septae permanently fuse due to the development of fibrous adhesions. Thus, all humans are born with a PFO and approximately 75% of PFOs fuse following childbirth. For the 25% of the population’s whose PFOs do not fuse, ~6% have what is considered by some to be a large PFO (> 2 mm). PFO diameter can increase with age. The concern with PFOs is that with a right to left shunt between the atria, venous emboli gas may pass from the right atrium (venous) to the left atrium (arterial) (“shunt”), thus by-passing the normal lung filtration of venous emboli which prevent passage to the arterial system. Without filtration, bubbles in the arterial system may lead to a neurological event such as a stroke. Any activity that increases the right atrium/venous pressure over the left atrium/arterial pressure (such as a Valsalva maneuver, abdominal compression) may further enable blood and/or emboli across a PFO/shunt.
      From: Nuffield Department of Clinical Neurosciences
      The purpose of this working group was to review and provide analysis on the status and progress of research and clinical activities intended to mitigate the risk of PFO and DCS issues during spaceflight. Identified cases of DCS during NASA exploration atmosphere ground testing conducted in pressurized chambers led to the prioritization of the given topic for external review. The main goals of the working group included:
      Quantification of any increased risk associated with the presence of a PFO during decompression protocols utilized in ground testing and spaceflight EVAs, as well as unplanned decompressions (e.g., cabin depressurization, EVA suit leak). Describe risks and benefits of PFO screening in astronaut candidates, current crewmembers, and chamber test subjects. What are potential risk reduction measures that could be considered if a person was believed to be at increased risk of DCS due to a PFO? What research and/or technology development is recommended that could help inform and/or mitigate PFO-related DCS risk? The working group took place over two days at NASA’s Johnson Space Center and included NASA subject matter experts and stakeholders, as well as invited external reviewers from areas including cardiology, hypobaric medicine, spaceflight medicine, and military occupational health. During the working group, participants were asked to review past reports and evidence related to PFOs and risk of DCS, materials and information regarding NASA’s current experience and practices, and case studies and subsequent decision-making processes. The working group culminated in an open-forum discussion where recommendations for current and future practices were conferred and subsequently summarized in a final summary report, available on the public NASA OCHMO Standards Team website.
      The following key findings are the main take-aways from the OCHMO independent assessment:
      In an extreme exposure/high-risk scenario, excluding individuals with a PFO and treating PFOs does not necessarily decrease the risk of DCS or create a ‘safe’ environment. It may create incremental differences and slightly reduce overall risk but does not make the risk zero. There are other physiological factors that also contribute to the risk of DCS that may have a larger impact (see 7.0 Other Physiological Factors in the findings section).  Based on the available evidence and the risk of current decompression exposures (based on current NASA protocols and NASA-STD-3001 requirements to limit the risk of DCS), it is not recommended to screen for PFOs in any spaceflight or ground testing participants. The best strategy to reduce the risk of DCS is to create as safe an environment as possible in every scenario, through effective prebreathe protocols, safety, and the capability to rapidly treat DCS should symptoms occur.  Based on opinion, no specific research is required at this time to further characterize PFOs with DCS and altitude exposure, due to the low risk and preference to institute adequate safe protocols and ensuring treatment availability both on the ground and in spaceflight. For engineering protocols conducted on the ground, it should be ensured that the same level of treatment capability (treatment chamber in the immediate vicinity of the testing) is provided as during research protocols. The ability to immediately treat a DCS case is critical in ensuring the safety of the test subjects. The full summary report includes detailed background information, discussion points from the working group, and conclusions and recommendations. The findings from the working group and resulting summary report will help to inform key stakeholders in decision-making processes for future ground testing and spaceflight operations with the main goal of protecting crew health and safety to ensure overall mission success.
      Summary Report About the Author
      Sarah D. Childress

      Share
      Details
      Last Updated Dec 31, 2024 Related Terms
      Office of the Chief Health and Medical Officer (OCHMO) Human Health and Performance Humans in Space International Space Station (ISS) Explore More
      2 min read Station Science Top News: Dec. 20, 2024
      Article 2 weeks ago 4 min read Artemis II Core Stage Vertical Integration Begins at NASA Kennedy
      Article 2 weeks ago 3 min read NASA, Axiom Space Change Assembly Order of Commercial Space Station
      Article 2 weeks ago Keep Exploring Discover More Topics From NASA
      Missions
      Humans in Space
      Climate Change
      Solar System
      View the full article
    • By NASA
      Humans are returning to the Moon—this time, to stay. Because our presence will be more permanent, NASA has selected a location that maximizes line-of-sight communication with Earth, solar visibility, and access to water ice: the Lunar South Pole (LSP). While the Sun is in the lunar sky more consistently at the poles, it never rises more than a few degrees above the horizon; in the target landing regions, the highest possible elevation is 7°. This presents a harsh lighting environment never experienced during the Apollo missions, or in fact, in any human spaceflight experience. The ambient lighting will severely affect the crews’ ability to see hazards and to perform simple work. This is because the human vision system, which despite having a high-dynamic range, cannot see well into bright light and cannot adapt quickly from bright to dark or vice versa. Functional vision is required to perform a variety of tasks, from simple tasks (e.g., walking, operating simple tools) through managing complex machines (e.g., lander elevator, rovers). Thus, the environment presents an engineering challenge to the Agency: one that must be widely understood before it can be effectively addressed.

       In past NASA missions and programs, design of lighting and functional vision support systems for extravehicular activity (EVA) or rover operations have been managed at the lowest program level. This worked well for Apollo and low Earth orbit because the Sun angle was managed by mission planning and astronaut self-positioning; helmet design alone addressed all vision challenges. The Artemis campaign presents new challenges to functional vision, because astronauts will be unable to avoid having the sun in their eyes much of the time they are on the lunar surface. This, combined with the need for artificial lighting in the extensive shadowing at the LSP, means that new functional vision support systems must be developed across projects and programs. The design of helmets, windows, and lighting systems must work in a complementary fashion, within and across programs, to achieve a system of lighting and vision support that enables crews to see into darkness while their eyes are light-adapted, in bright light while still dark-adapted, and protects their eyes from injury.
      Many of the findings of the assessment were focused on the lack of specific requirements to prevent functional vision impairment by the Sun’s brilliance (which is different from preventing eye injury), while enabling astronauts to see well enough to perform specific tasks. Specifically, tasks expected of astronauts at the LSP were not incorporated into system design requirements to enable system development that ensures functional vision in the expected lighting environment. Consequently, the spacesuit, for example, has flexibility requirements for allowing the astronauts to walk but not for ensuring they can see well enough to walk from brilliant Sun into a dark shadow and back without the risk of tripping or falling. Importantly, gaps were identified in allocation of requirements across programs to ensure that the role of the various programs is for each to understand functional vision. NESC recommendations were offered that made enabling functional vision in the harsh lighting environment a specific and new requirement for the system designers. The recommendations also included that lighting, window, and visor designs be integrated.
      The assessment team recommended that a wide variety of simulation techniques, physical and virtual, need to be developed, each with different and well-stated capabilities with respect to functional vision. Some would address the blinding effects of sunlight at the LSP (not easily achieved through virtual approaches) to evaluate performance of helmet shields and artificial lighting in the context of the environment and adaptation times. Other simulations would add terrain features to identify the threats in simple (e.g., walking, collection of samples) and complex (e.g., maintenance and operation of equipment) tasks. Since different facilities have different strengths, they also have different weaknesses. These strengths and limitations must be characterized to enable verification of technical solutions and crew training.
      NESC TB 2024- discipline-focus-hfView the full article
    • By NASA
      Download PDF: Statistical Analysis Using Random Forest Algorithm Provides Key Insights into Parachute Energy Modulator System

      Energy modulators (EM), also known as energy absorbers, are safety-critical components that are used to control shocks and impulses in a load path. EMs are textile devices typically manufactured out of nylon, Kevlar® and other materials, and control loads by breaking rows of stitches that bind a strong base webbing together as shown in Figure 1. A familiar EM application is a fall-protection harness used by workers to prevent injury from shock loads when the harness arrests a fall. EMs are also widely used in parachute systems to control shock loads experienced during the various stages of parachute system deployment.
      Random forest is an innovative algorithm for data classification used in statistics and machine learning. It is an easy to use and highly flexible ensemble learning method. The random forest algorithm is capable of modeling both categorical and continuous data and can handle large datasets, making it applicable in many situations. It also makes it easy to evaluate the relative importance of variables and maintains accuracy even when a dataset has missing values.
      Random forests model the relationship between a response variable and a set of predictor or independent variables by creating a collection of decision trees. Each decision tree is built from a random sample of the data. The individual trees are then combined through methods such as averaging or voting to determine the final prediction (Figure 2). A decision tree is a non-parametric supervised learning algorithm that partitions the data using a series of branching binary decisions. Decision trees inherently identify key features of the data and provide a ranking of the contribution of each feature based on when it becomes relevant. This capability can be used to determine the relative importance of the input variables (Figure 3). Decision trees are useful for exploring relationships but can have poor accuracy unless they are combined into random forests or other tree-based models.
      The performance of a random forest can be evaluated using out-of-bag error and cross-validation techniques. Random forests often use random sampling with replacement from the original dataset to create each decision tree. This is also known as bootstrap sampling and forms a bootstrap forest. The data included in the bootstrap sample are referred to as in-the-bag, while the data not selected are out-of-bag. Since the out-of-bag data were not used to generate the decision tree, they can be used as an internal measure of the accuracy of the model. Cross-validation can be used to assess how well the results of a random forest model will generalize to an independent dataset. In this approach, the data are split into a training dataset used to generate the decision trees and build the model and a validation dataset used to evaluate the model’s performance. Evaluating the model on the independent validation dataset provides an estimate of how accurately the model will perform in practice and helps avoid problems such as overfitting or sampling bias. A good model performs well on
      both the training data and the validation data.
      The complex nature of the EM system made it difficult for the team to identify how various parameters influenced EM behavior. A bootstrap forest analysis was applied to the test dataset and was able to identify five key variables associated with higher probability of damage and/or anomalous behavior. The identified key variables provided a basis for further testing and redesign of the EM system. These results also provided essential insight to the investigation and aided in development of flight rationale for future use cases.
      For information, contact Dr. Sara R. Wilson. sara.r.wilson@nasa.gov
      View the full article
    • By Space Force
      The Space Force Personnel Management Act marks a significant step towards the evolving structure of the USSF by integrating and streamlining active-component Guardians and Air Force Reservists in space-focused career fields to offer both full- and part-time service options.

      View the full article
  • Check out these Videos

×
×
  • Create New...